跳至主要内容
临床试验/ISRCTN10186987
ISRCTN10186987招募中不适用

Effect of PRAvastatin in Pregnancies complicated by Ischemical Placental Disease: prospective observational study

Aristotle University of Thessaloniki0 个研究点目标入组 70 人开始时间: 2018年3月17日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
Female

入选标准

  • 1. Pregnant women with PE and/or IUGR diagnosed between 20 and 34 gestational weeks, irrespective of maternal age.
  • 2. PE will be defined as a newly onset hypertension in pregnancy (SAP > 140 mm ?g or DAP > 90 mm ?g) and significant proteinuria (>300mg/24h)
  • 3. IUGR is defined as an estimated fetal weight <10th percentile with associated findings of placental insufficiency as a high resistance in the uterine arteries or in the umbilical artery (Pulsatility Index>95th percentile) or reduced amniotic fluid (maximum vertical pocket < 2 cm)
  • The control group:
  • 1. Historical sample of women that were hospitalised during the 5 previous years in the Maternal fetal medicine unit of the 3rd Obstetrics and Gynecology University clinic
  • 2. Pravastatin not used in treating the disease
  • 3. Controlled for maternal age and the estimated fetal weight percentile.

排除标准

  • 1. Pre-existing hypertension
  • 3. Liver or connective tissue disease
  • 4. Uterine malformations
  • 5. Twin pregnancy
  • 6. Fetal chromosomal abnormalities

研究者

相似试验